Corient Private Wealth LLC Increases Position in Colgate-Palmolive (NYSE:CL)

Corient Private Wealth LLC lifted its position in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 9.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 598,470 shares of the company's stock after buying an additional 52,390 shares during the period. Corient Private Wealth LLC owned about 0.07% of Colgate-Palmolive worth $54,115,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently modified their holdings of the company. State Street Corp boosted its position in shares of Colgate-Palmolive by 3.8% during the third quarter. State Street Corp now owns 48,436,276 shares of the company's stock worth $5,028,170,000 after buying an additional 1,784,411 shares during the period. Geode Capital Management LLC boosted its position in shares of Colgate-Palmolive by 2.8% during the third quarter. Geode Capital Management LLC now owns 20,193,331 shares of the company's stock worth $2,095,325,000 after buying an additional 552,949 shares during the period. Massachusetts Financial Services Co. MA boosted its position in shares of Colgate-Palmolive by 6.2% during the third quarter. Massachusetts Financial Services Co. MA now owns 9,526,990 shares of the company's stock worth $988,997,000 after buying an additional 557,492 shares during the period. Amundi boosted its position in shares of Colgate-Palmolive by 12.8% during the fourth quarter. Amundi now owns 9,200,144 shares of the company's stock worth $806,015,000 after buying an additional 1,040,604 shares during the period. Finally, Barclays PLC boosted its position in shares of Colgate-Palmolive by 38.7% during the third quarter. Barclays PLC now owns 7,644,189 shares of the company's stock worth $793,542,000 after buying an additional 2,132,747 shares during the period. 80.41% of the stock is owned by institutional investors and hedge funds.

Remove Ads

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on the company. Morgan Stanley dropped their target price on Colgate-Palmolive from $111.00 to $104.00 and set an "overweight" rating on the stock in a report on Monday, February 3rd. Barclays dropped their target price on Colgate-Palmolive from $96.00 to $83.00 and set an "equal weight" rating on the stock in a report on Friday, January 17th. Stifel Nicolaus dropped their target price on Colgate-Palmolive from $95.00 to $93.00 and set a "hold" rating on the stock in a report on Monday, February 3rd. Raymond James reiterated an "outperform" rating and set a $105.00 target price (down previously from $110.00) on shares of Colgate-Palmolive in a report on Monday, February 3rd. Finally, Wells Fargo & Company dropped their target price on Colgate-Palmolive from $92.00 to $83.00 and set an "underweight" rating on the stock in a report on Tuesday, January 7th. One analyst has rated the stock with a sell rating, ten have assigned a hold rating and eleven have given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus target price of $101.72.

Colgate-Palmolive Price Performance

NYSE:CL traded down $0.15 during midday trading on Thursday, hitting $90.29. The company had a trading volume of 5,570,261 shares, compared to its average volume of 4,200,518. Colgate-Palmolive has a 52-week low of $85.32 and a 52-week high of $109.30. The stock's fifty day moving average price is $89.19 and its 200-day moving average price is $94.41. The company has a market capitalization of $73.28 billion, a PE ratio of 25.65, a P/E/G ratio of 4.20 and a beta of 0.40. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40.

Colgate-Palmolive (NYSE:CL - Get Free Report) last posted its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter last year, the business earned $0.87 earnings per share. As a group, research analysts expect that Colgate-Palmolive will post 3.75 earnings per share for the current year.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.